-
Vivera Pharmaceuticals Innovative Approach towards Opioid Crisis
Medical science has reached new peaks in the recent decade. However, in these challenging times, the healthcare space is developing new-age solutions to combat world problems and overcome them. World leaders aid the healthcare bodies to assist in developing new drugs for the public welfare. Among these crises, the opioid epidemic is one of the significant emergencies the world is facing.
Opioid Epidemic
Opioids are compounds extracted from poppy plants’ seeds that interact with the opioid receptors in the brain. Most commonly used for pain treatment and therapy, opioids are a compound in morphine, tramadol, heroin, methadone and fentanyl compositions. However, prescription drug use is highly prevalent in the world, leading to a significant drug addiction problem. Non-medical misuse of opioids leads to various health issues like respiratory problems, organ failure, and overdoses can lead to death. More than half a million people worldwide succumb to opioid addiction every year. Though Naloxone can prevent death due to an opioid overdose, hardly 10% of people suffering from the addiction get it.
Vivera’s Inspiration to combat prescription drug abuse
Vivera Pharmaceuticals CEO, Paul Edalat, shared his inspiration for developing such software. Edalat’s brother was suffering from an aggressive form of Hodgkin’s lymphoma, a severe type of cancer. His prescription drugs included opioids to help him manage the pain. However, such high doses of opioids soon turned into addictions; towards the end, he could not function without them. Edalat’s brother ultimately lost his battle with cancer and addiction, making Edalat realize the severity of prescription drug abuse.
ZICOH
Following his harrowing past with prescription drug abuse, Vivera Pharmaceuticals team worked to successfully develop ZICOH – an electronic device that delivers medications in prescribed and controlled doses. ZICOH revolutionized the way we see medication dosage with its intelligent software. ZICOH is patented and works with ZICOH Connect. It is a synchronized software that collects, aggregates and dispenses prescribed data so that patients have an idea of how much medication they are taking. The device actively helps in keeping a check on the drug dosage, aiding patients in maintaining the prescribed amount for consumption. ZICOH, being the first of its kind, can successfully stop addiction from the state it needs to be controlled. With a known dosage, patients can keep track of the opioids preventing the addiction stage.
Challenges
The healthcare industry is a challenging area to begin with. Collecting and analyzing medical data while adhering to the prescription for individual patients in accordance with their health issues needs great precision. The healthcare industry is resistant to change, sticking to the tried and tested medicines, often overlooking the benefits of new compositions. Therefore, commercializing a product that is going to block one of the major global issues is a significant challenge for the team. However, with the latest technology and an invested workforce, Edalat’s team is reaching new heights with this life-saving technology.
Conclusion
Vivera Pharmaceuticals believes in giving back to society. They are vocal about this and work dedicatedly to solve the issues faced by the people. Working with medical providers and organizations, Vivera works to help vulnerable communities worldwide with their cutting-edge software.
-
Mr. Paul Edalat Efforts Towards TABMELT: A Sublingual Drug Delivery System That’s Really Taking Off
Paul Edalat has over 30 years of experience in the pharmaceutical and nutraceutical industries. He is the founder and CEO of Vivera Pharmaceuticals, a company that is dedicated to changing how people receive treatment. The company’s expansion into technologies such as medical devices and telemedicine allows patients to receive treatment from anywhere in the world.
TABMELT is a patent-protected, sublingual drug delivery system that is designed to provide quick, controlled, and easily manageable drug delivery. TABMELT uses an innovative design that provides all the benefits of rapid dissolution with a sustained release profile without the use of a standard pill or tablet.
TABMELT: A Sublingual Drug Delivery System That’s Really Taking Off
TABMELT is a unique sublingual drug delivery system that is taking the world by storm. This innovative product has been designed to provide a convenient and effective way for patients to take their medication. The TABMELT system utilizes a simple, yet effective, tablet that dissolves quickly under the tongue, delivering the medication directly into the bloodstream.
This means that patients can avoid the hassle of having to take their medication orally, which can often be difficult, time-consuming, and uncomfortable. Additionally, TABMELT offers a more discreet alternative to traditional methods of drug delivery, such as injections or patches.
The TABMELT system is already being used by thousands of patients around the world and its popularity is only increasing. Thanks to its many benefits, TABMELT is quickly becoming the preferred choice for those who need an easy and effective way to take their medication.
Why Tabmelt is Such a Game Changer for Drugs and Medications
Tabmelt is a sublingual drug delivery system that is taking the pharmaceutical industry by storm. The system uses pressure-sensitive microchips to deliver medication directly to the bloodstream, bypassing the digestive system. This allows for faster absorption of the medication and more efficient treatment. Tabmelt is also much easier to use than traditional pill forms of medication, and it doesn’t require water or food to take.
The Tabmelt system has already been used successfully to deliver medications for conditions like pain, anxiety, and migraines. The potential applications for Tabmelt are endless, and it has the potential to revolutionize the way we take drugs and medications.
Paul Edalat and his company working on the TABMELT sublingual drug delivery system, which helps patients absorb medications through their mucous membranes. This system is more efficient than traditional pill-based systems and allows for a more tailored approach to medication. In addition, MDZone provides a self-contained portable station that patients can use to connect with remote, HIPAA-compliant medical care. This system allows for greater access to care and helps patients stay connected with their doctors.
Meet The Man Developing Novel Approaches To Improve Human Health
Paul Edalat has over 30 years of experience in the pharmaceutical and nutraceutical industries. He is the founder and CEO of Vivera Pharmaceuticals, a company that is dedicated to changing how people receive treatment. The company’s expansion into technologies such as medical devices and telemedicine allows patients to receive treatment from anywhere in the world.
TABMELT is a patent-protected, sublingual drug delivery system that is designed to provide quick, controlled, and easily manageable drug delivery. TABMELT uses an innovative design that provides all the benefits of rapid dissolution with a sustained release profile without the use of a standard pill or tablet.
TABMELT: A Sublingual Drug Delivery System That’s Really Taking Off
TABMELT is a unique sublingual drug delivery system that is taking the world by storm. This innovative product has been designed to provide a convenient and effective way for patients to take their medication. The TABMELT system utilizes a simple, yet effective, tablet that dissolves quickly under the tongue, delivering the medication directly into the bloodstream.
This means that patients can avoid the hassle of having to take their medication orally, which can often be difficult, time-consuming, and uncomfortable. Additionally, TABMELT offers a more discreet alternative to traditional methods of drug delivery, such as injections or patches.
The TABMELT system is already being used by thousands of patients around the world and its popularity is only increasing. Thanks to its many benefits, TABMELT is quickly becoming the preferred choice for those who need an easy and effective way to take their medication.
Why Tabmelt is Such a Game Changer for Drugs and Medications
Tabmelt is a sublingual drug delivery system that is taking the pharmaceutical industry by storm. The system uses pressure-sensitive microchips to deliver medication directly to the bloodstream, bypassing the digestive system. This allows for faster absorption of the medication and more efficient treatment. Tabmelt is also much easier to use than traditional pill forms of medication, and it doesn’t require water or food to take.
The Tabmelt system has already been used successfully to deliver medications for conditions like pain, anxiety, and migraines. The potential applications for Tabmelt are endless, and it has the potential to revolutionize the way we take drugs and medications.
Paul Edalat and his company working on the TABMELT sublingual drug delivery system, which helps patients absorb medications through their mucous membranes. This system is more efficient than traditional pill-based systems and allows for a more tailored approach to medication. In addition, MDZone provides a self-contained portable station that patients can use to connect with remote, HIPAA-compliant medical care. This system allows for greater access to care and helps patients stay connected with their doctors.
Meet The Man Developing Novel Approaches To Improve Human Health
Mr. Paul Edalat has devoted his career to developing novel approaches to improve human health. Vivera Pharmaceuticals is a unique company that is focused on developing products that address unmet medical needs. The company’s mission is to improve the lives of patients by providing them with safe and effective treatments. Vivera Pharmaceuticals is committed to researching and developing new drugs and therapies that will make a difference in the lives of patients. The company’s team of experts is constantly searching for new ways to improve human health. Mr. Edalat’s experience and passion for improving human health make Vivera Pharmaceuticals different from any other pharmaceutical company. The company’s commitment to innovation and its dedication to helping patients live better lives sets it apart from its competitors.
Conclusion
In conclusion, Mr. Paul Edalat‘s efforts towards TABMELT are commendable and his dedication to improving human health is evident. The company he founded, Vivera Pharmaceuticals, is committed to researching and developing new drugs and therapies to make a difference in the lives of patients. The company’s team of experts is constantly searching for new ways to improve human health. Thanks to its many benefits, TABMELT is quickly becoming the preferred choice for those who need an easy and effective way to take their medication.
-
Revolutionizing Healthcare: How Vivera Pharmaceuticals Is Changing The Pharmaceutical Industry
Vivera Pharmaceuticals is a company that is set to change the pharmaceutical industry. Through its innovative patient-centric solutions, the company is revolutionizing healthcare.
The Goal of Vivera Pharmaceuticals
The goal of Vivera Pharmaceuticals is to develop and commercialize new treatments that improve the lives of patients with serious diseases. The company has a portfolio of products in development for a variety of indications, including cancer, infectious diseases, and inflammatory diseases.
Vivera Pharmaceuticals is committed to improving the lives of patients with serious diseases by developing and commercializing new treatments. The company’s pipeline includes product candidates with the potential to treat a variety of indications, including cancer, infectious diseases, and inflammatory diseases.
Healthcare in the United States
The United States has long been an international leader in healthcare, both in terms of the quality of care and the development of new treatments and technologies. However, the high cost of healthcare is a major challenge for many Americans, as is access to care.
Vivera Pharmaceuticals is a leading pharmaceutical company that is working to revolutionize healthcare in the United States. The company is focused on developing new treatments and technologies that can improve patient outcomes while reducing costs.
In addition to its work in research and development, Vivera is also committed to increasing access to healthcare in the United States. The company provides free or low-cost health insurance to its employees and offers discounts on medications and other products to patients who cannot afford them.
How Vivera plans to change the industry with patient-centric solutions
In an industry that has been slow to adopt change, Vivera Pharmaceuticals is leading the charge in developing patient-centric solutions that aim to improve outcomes and increase access to care.
With a focus on customer service and engagement, Vivera is working to create a more seamless experience for patients as they navigate the often-complex healthcare system. The company’s suite of digital tools and services is designed to empower patients and help them make informed decisions about their health.
In addition to its consumer-facing offerings, Vivera is also working to develop new products and therapies that address unmet medical needs. The company’s pipeline includes treatments for rare diseases, cancers, and other conditions that have been historically underserved by the pharmaceutical industry.
-
Why The World Needs Innovative Pharmaceutical Companies Like Vivera Pharmaceuticals
Some of the most critical and life-saving items on the market are pharmaceuticals. People go to them for help with everything from colds to cancer. But many pharmaceutical companies are having trouble, even though they are very significant. In this article, we’ll talk about why this is happening and how you can help fix it. From coming up with new ways to market pharmaceuticals to making biotech drugs more of a threat, there are many ways you can help improve the pharmaceutical industry.
The Challenges Faced By Pharmaceutical Companies
There are a lot of problems that pharmaceutical companies have to deal with today. One of the most important is that generic drugs are becoming more and more of a threat. Generic medicines are made by companies that replicate the ingredients and ways that brand-name drugs are made and then sell them for less money. Because of this, pharmaceutical companies lose money on every drug they make, so they have less money to spend on research and development.
How Innovative Pharmaceutical Companies Can Address These Challenges
There are a number of reasons why the world needs innovative pharmaceutical companies like Vivera Pharmaceuticals. Here are a few:
#1 Improvement in medical technology
As medical technology has improved, patients have been able to get better care, such as better diagnoses and more effective treatments. Because of this, there is a greater need for new pharmaceuticals that can help meet these needs.
#2 Increased demand from emerging markets
The global market for pharmaceuticals is still being driven by the growth of emerging markets. In these markets, as a result of population growth, the economy is growing quickly, and the need for health care is rising. As these countries look for new and better treatments to meet the needs of their citizens, they offer a big chance for innovative pharmaceutical companies like Vivera Pharmaceuticals.
#3 Increasing competition from generic manufacturers
Some of the most critical and life-saving items on the market are pharmaceuticals. People go to them for help with everything from colds to cancer. But many pharmaceutical companies are having trouble, even though they are very significant. In this article, we’ll talk about why this is happening and how you can help fix it. From coming up with new ways to market pharmaceuticals to making biotech drugs more of a threat, there are many ways you can help improve the pharmaceutical industry.
The Challenges Faced By Pharmaceutical Companies
There are a lot of problems that pharmaceutical companies have to deal with today. One of the most important is that generic drugs are becoming more and more of a threat. Generic medicines are made by companies that replicate the ingredients and ways that brand-name drugs are made and then sell them for less money. Because of this, pharmaceutical companies lose money on every drug they make, so they have less money to spend on research and development.
How Innovative Pharmaceutical Companies Can Address These Challenges
There are a number of reasons why the world needs innovative pharmaceutical companies like Vivera Pharmaceuticals. Here are a few:
#1 Improvement in medical technology
As medical technology has improved, patients have been able to get better care, such as better diagnoses and more effective treatments. Because of this, there is a greater need for new pharmaceuticals that can help meet these needs.
#2 Increased demand from emerging markets
The global market for pharmaceuticals is still being driven by the growth of emerging markets. In these markets, as a result of population growth, the economy is growing quickly, and the need for health care is rising. As these countries look for new and better treatments to meet the needs of their citizens, they offer a big chance for innovative pharmaceutical companies like Vivera Pharmaceuticals.
#3 Increasing competition from generic manufacturers
Original drug makers are getting more and more competition from generic drug makers for their market share. Many of the original drug makers have seen their profits drop because of this competition. This has put pressure on them to find new ways to stay in business. Innovative pharmaceutical companies like Vivera Pharmaceuticals can help solve this problem by making new medications that are hard for generic manufacturers to copy.
#4 Expansion of the biotechnology industry
The biotechnology industry is growing rapidly due to advances in gene sequencing and other technologies. This sector provides opportunities for innovative pharmaceutical companies as they develop new treatments using biotechnological methods.
Conclusion
We live in a time when there is a greater need than ever for new and innovative pharmaceutical companies like Vivera Pharmaceuticals. There are many diseases that haven’t had a cure in years or even decades, and the drugs on the market right now don’t always give patients the best options. By putting trust and money into these kinds of innovative companies, we can help change that and make it easier for people to get treatments.
-
Paul Edalat, Chairman & CEO of Vivera Pharmaceuticals shares his outlook on the company
At the beginning of the year, Vivera Pharmaceuticals announced its CEO & Chairman, Paul Edalat has joined the Forbes business council. The invitation was only for growth and networking for companies with successful leaders like Paul Edalat.
” I’m Honored to be invited into the Forbes business council. Since the beginning of my career, I was given immense opportunities to become the entrepreneur I’m today. I would love to take this opportunity to share my knowledge with fellow entrepreneurs. ”
Vivera Pharmaceuticals believes in science with technology integration to develop innovative and effective drugs for various treatments. Under the leadership of Paul Edalat, Vivera Pharmaceuticals have grown immensely. Vivera welcomed many talented executives onboard and adopted technology to keep up with the fast-paced environment.
Vivera has achieved two patents for ZICOH, a dose-controlled medical device that is designed to prevent the misuse of medication prescriptions. In a world where people are finding ways to misuse medications, Vivera Pharmaceuticals believes in keeping patients first. Paul Edalat shares key elements that set Vivera apart:
Technology-driven development in the medical field
Vivera Pharmaceutical believes in the power of data and technology. We have developed medical devices, and drugs based on scientific data-driven technologies. Our scientists make use of the latest technology to empower innovation. We understand the need for technology in the biotech and pharmaceutical industry. That’s why we have integrated technology in every way possible in our manufacturing process.
Care for people
Paul Edalat keeps in mind the need of people, we at Vivera pharmaceuticals understand the need of people. We know how critical drugs and medical devices are to optimize and empower lives. To ensure the best quality in every way possible our products pass through stringent quality tests.
Under the strong and visionary leader of Paul Edalat, Vivera Pharmaceuticals has reached new levels. Especially after the pandemic, and the way the CEO handled the challenges. Executives and the leadership team analyzed every challenge and offered the best results.
As a result, Paul Edalat was invited by Forbes to share their experience with the industry in such a volatile time. Now that the world is facing recession, Vivera Pharmaceutical is working effectively on our industry with bold and well-informed actions to succeed. These bold decisions with the support of expert and educated staff become even more effective.
About Vivera Pharmaceuticals
Vivera pharmaceuticals is an innovative, science and tech-driven pharmaceutical company with its base in Southern California. The company has focused on research, development, and innovation in patent-centric theories as well as medical devices. Vivera Pharmaceuticals have global exclusivity with a license to patent as well as patent-pending TABMELT, a sublingual drug delivery system for use in the pharmaceutical industry.
Vivera Pharmaceuticals holds its patent issued on ZICOH, a dose-controlled medical device. The company has a notice of allowance for a portable telemedicine station, MDZone. Vivera Pharmaceuticals have divisions including advanced diagnosis, Bio-Science, Medical Technologies, Neurosciences
About Paul Edalat
Paul Edalat has 30 years of experience in the pharmaceutical industry. He is the founder, Chairman, and CEO of VIvera Pharmaceuticals. He is on a mission to improve the outdated pharmaceutical industry into a science and tech-driven industry. Working with an incredible team of scientists, advisors, and executives, Paul Edalat has developed a growing pharmaceutical company. The company has a patented medical device, ZICOH, and has a patent pending system TABMELT. He is a member of the Forbes business council and an honorable nominee in the 2022 Innovator of The Year Awards and The OBCJ’s 2022 Excellence in Entrepreneur Awards. Edalat was also listed as a CEO Visionary in The LA Times’ B2B Magazine.
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Paul Edalat 